Screener
UroGen Pharma URGN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's short-term investments?
- UroGen Pharma (URGN) reported short-term investments of $28.84M in Q2 2026.
- How has UroGen Pharma's short-term investments changed year-over-year?
- UroGen Pharma's short-term investments decreased by 55.0% year-over-year, from $64.05M to $28.84M.
- What is the long-term trend for UroGen Pharma's short-term investments?
- Over 5 years (2020 to 2025), UroGen Pharma's short-term investments has grown at a -27.7% compound annual growth rate (CAGR), from $49.15M to $9.71M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about UroGen Pharma's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude